Physician

Andrew Francis Leigh Gross, M.D.

According to 2025 Medicare claims, Andrew Gross, M.D. (NPI: 1730322843) practices neurosurgery in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Iredell, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1760288633; TIN: 862109896) and primary practice location at 28117-8525. Gross is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and CHSPSC ACO 14, LLC (ACO ID: A3724), participating under the MSSP model.

Gross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 476 traditional Medicare patients, billed 7,235 HCPCS/CPT codes, and received $112,267 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,538 prescription claims across 386 beneficiaries totaling $128,681 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 11 claims. Open Payments data shows 23 records totaling $450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $105,713 and ending at $128,681. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,650 to $12,010.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	429	2,004	$113,060
2016	496	2,293	$116,533
2017	534	3,522	$127,270
2018	565	3,584	$135,679
2019	579	4,692	$145,063
2020	533	5,281	$129,374
2021	494	6,148	$133,139
2022	480	5,344	$121,610
2023	469	6,546	$120,014
2024	476	7,235	$112,267

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	116	472	$105,713
2016	234	975	$238,657
2017	285	1,366	$395,509
2018	318	1,429	$320,465
2019	400	1,822	$1,005,195
2020	457	2,007	$982,505
2021	428	1,763	$563,198
2022	462	1,874	$359,164
2023	424	1,730	$257,014
2024	386	1,538	$128,681

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$332
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	87	91	$122
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	111	111	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	90	105	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	133	161	$60
92083	Exam of visual field with extended testing	73	94	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	14	828	$16,105
Pyridostigmine Bromide	Pyridostigmine Bromide	83	6,370	$6,956
Memantine Hcl	Memantine Hcl	70	5,405	$5,216
Carbidopa-Levodopa	Carbidopa/Levodopa	78	6,366	$3,286
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	13	800	$3,265

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$450	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Francis Leigh Gross, M.D.?

Tedicare shows public-source Medicare data for Andrew Francis Leigh Gross, M.D. (NPI 1730322843), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Francis Leigh Gross, M.D. have ACO affiliation data?

Andrew Francis Leigh Gross, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and CHSPSC ACO 14, LLC (MSSP, ACO ID A3724).

What billing organization is linked to Andrew Francis Leigh Gross, M.D.?

Andrew Francis Leigh Gross, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1760288633) in the available physician profile data.

Does Andrew Francis Leigh Gross, M.D. have Open Payments data?

Andrew Francis Leigh Gross, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.